These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 914959)

  • 21. Effect of diphosphopyridine nucleotide on the inhibition of rat liver 3-hydroxyanthranilic-acid oxidase by 2-acetylaminofluorene and N-2-fluorenyl-diacetamide.
    QUAGLIARIELLO E; AURICCHIO S; RINALDI E; RUBINO A
    Nature; 1958 Dec; 182(4651):1744. PubMed ID: 13622647
    [No Abstract]   [Full Text] [Related]  

  • 22. Metabolism of 2-aminofluorene and 2-acetylaminofluorene to mutagens by rat hepatocyte nuclei.
    Stout DL; Becker FF
    Cancer Res; 1979 Apr; 39(4):1168-73. PubMed ID: 421200
    [No Abstract]   [Full Text] [Related]  

  • 23. Microsomal N-hydroxylase modification as a first step in carcinogenesis by arylamines [proceedings].
    Roberfroid M; Razzouk C; Mercier M
    Arch Int Physiol Biochim; 1977 Apr; 85(2):429-31. PubMed ID: 71125
    [No Abstract]   [Full Text] [Related]  

  • 24. Dietary lipid-dependent activation of the carcinogen N-2-fluorenylacetamide in rats as monitored by Salmonella typhimurium.
    Castro CE; Felkner IC; Yang SP
    Cancer Res; 1978 Sep; 38(9):2836-41. PubMed ID: 354780
    [No Abstract]   [Full Text] [Related]  

  • 25. In vitro metabolism and mutagenic activation of 2-acetylaminofluorene by subcellular liver fractions from Cotton rats.
    Schut HA; Thorgeirsson SS
    Cancer Res; 1978 Aug; 38(8):2501-7. PubMed ID: 352509
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of piperonyl butoxide on hydroxylation of 2-acetylaminofluorene in hamster liver.
    Friedman MA; Woods S
    Res Commun Chem Pathol Pharmacol; 1977 Aug; 17(4):623-30. PubMed ID: 897350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intestinal microflora enhances formation of DNA adducts following administration of 2-NF and 2-AAF.
    Möller L; Zeisig M; Midtvedt T; Gustafsson JA
    Carcinogenesis; 1994 May; 15(5):857-61. PubMed ID: 8200087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Absorption and protein binding of N-2-fluorenylacetamide and its metabolites in the bladder of rabbit.
    Hopp ML; Matsumoto M; Lee C; Oyasu R
    J Natl Cancer Inst; 1977 Feb; 58(2):281-5. PubMed ID: 833876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Main pathway for mutagenic activation of 2-acetylaminofluorene by guinea pig liver homogenates.
    Kaneda S; Seno T; Takeishi K
    Biochem Biophys Res Commun; 1979 Oct; 90(3):750-6. PubMed ID: 116658
    [No Abstract]   [Full Text] [Related]  

  • 30. DNA adduct formation in liver following the administration of [3H]2-nitrofluorene to rats in vivo.
    Wierckx FC; Wedzinga R; Timmers-Reker AJ; Beland FA; Meerman JH; Mulder GJ
    Carcinogenesis; 1991 Nov; 12(11):2053-8. PubMed ID: 1718618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Partial purification and characterization of two enzymes from guinea-pig liver microsomes that hydrolyze carcinogenic amides 2-acetylaminofluorene and N-hydroxy-2-acetylaminofluorene.
    Järvinen M; Santti RS; Hopsu-Havu VK
    Biochem Pharmacol; 1971 Nov; 20(11):2971-82. PubMed ID: 5132107
    [No Abstract]   [Full Text] [Related]  

  • 32. The relationship of 2-acetamidofluorene mutagenicity in plate tests with its in vivo liver cell component distribution and its carcinogenic potential.
    McGregor D
    Mutat Res; 1975 Dec; 30(3):305-15. PubMed ID: 1105163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of microsomal N-hydroxylation of N-2-fluorenylacetamide in rat liver.
    Malejka-Giganti D; McIver RC; Glasebrook AL; Gutmann HR
    Biochem Pharmacol; 1978 Jan; 27(1):61-9. PubMed ID: 413553
    [No Abstract]   [Full Text] [Related]  

  • 34. Alteration of the ability of liver microsomes to activate N-2-fluorenylacetamide to a mutagen of Salmonella typhimurium during hepatocarcinogenesis.
    Stout DL; Becker FF
    Cancer Res; 1978 Aug; 38(8):2274-8. PubMed ID: 208764
    [No Abstract]   [Full Text] [Related]  

  • 35. Partial persistency of 2-aminofluorene and N-acetyl-2-aminofluorene in rat liver DNA.
    Visser A; Westra JG
    Carcinogenesis; 1981; 2(8):737-40. PubMed ID: 7285280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ascorbic acid inhibits covalent binding of enzymatically generated 2-acetyl-aminofluororene-N-sulfate to DNA under conditions in which it increases mutagenesis in salmonella TA-1538.
    Andrews LS; Fysh JM; Hinson JA; Gillette JR
    Life Sci; 1979 Jan; 24(1):59-63. PubMed ID: 763069
    [No Abstract]   [Full Text] [Related]  

  • 37. Formation and removal of specific acetylaminofluorene-DNA adducts in mouse and human cells measured by radioimmunoassay.
    Poirier MC; Dubin MA; Yuspa SH
    Cancer Res; 1979 Apr; 39(4):1377-81. PubMed ID: 421221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolism and activation of 2-acetylaminofluorene in isolated rat hepatocytes.
    Dybing E; Søderlund E; Haug LT; Thorgeirsson SS
    Cancer Res; 1979 Aug; 39(8):3268-75. PubMed ID: 455309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chromatographic separation of some metabolites of the carcinogen N-2-fluorenylacetamide.
    MORRIS HP; SOBER HA; WEISBURGER EK; WEISBURGER JH
    J Natl Cancer Inst; 1956 Sep; 17(3):363-74. PubMed ID: 13367807
    [No Abstract]   [Full Text] [Related]  

  • 40. Procarcinogen activation and hormonal control of cell proliferation in differentiated primary adult rat liver cell cultures.
    Leffert HL; Moran T; Boorstein R; Koch KS
    Nature; 1977 May; 267(5606):58-61. PubMed ID: 558527
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.